Literature DB >> 20004389

An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men.

Ahmad Hammoud1, Douglas T Carrell, A Wayne Meikle, Yuanpei Xin, Steven C Hunt, Ted D Adams, Mark Gibson.   

Abstract

OBJECTIVE: To describe the influence of the TTTA aromatase polymorphism (TTTAn) on the relation between obesity and plasma estradiol (E(2)) in obese men.
DESIGN: A 2-year cohort study.
SETTING: Clinical research center. PATIENT(S): Severely obese men (31 who had had gastric bypass surgery and 118 controls). INTERVENTION(S): Men were genotyped for the TTTAn CYP19A1 polymorphism. Anthropomorphic measures, plasma E(2), and other hormonal levels were determined at baseline and 2-year follow-up. MAIN OUTCOMES MEASURE(S): Relationships between weight and changes in weight and plasma E(2) were examined in relation to the TTTAn polymorphism. RESULT(S): The mean age was 46.5 ± 10.82 years, and mean body mass index was 47.1 ± 8.46 kg/m(2). The most common repeats were 7 and 11. TTTAn number did not correlate with plasma E(2) in the univariate analysis. When patients were stratified per weight group, the correlation between plasma E(2) and weight was seen only among men with a higher TTTA repeat at baseline and 2 years. Similarly, only men with higher TTTA exhibited reduced E(2) levels after weight loss. CONCLUSION(S): A higher TTTA repeat is associated with a strengthened relationship between obesity and E(2). The well-established effect of increased weight on plasma E(2) appears to be absent in men with low TTTA numbers.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004389      PMCID: PMC3719845          DOI: 10.1016/j.fertnstert.2009.10.037

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  43 in total

1.  Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery.

Authors:  Ted D Adams; Erick Avelar; Tom Cloward; Ross D Crosby; Robert J Farney; Richard Gress; R Chad Halverson; Paul N Hopkins; Ronette L Kolotkin; Michael J Lamonte; Sheldon Litwin; Robert T Nuttall; Robert Pendleton; Wayne Rosamond; Steven C Simper; Sherman C Smith; Michael Strong; James M Walker; Gail Wiebke; Frank G Yanowitz; Steven C Hunt
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

2.  CYP19 (aromatase) haplotypes and endometrial cancer risk.

Authors:  Randi A Paynter; Susan E Hankinson; Graham A Colditz; Peter Kraft; David J Hunter; Immaculata De Vivo
Journal:  Int J Cancer       Date:  2005-08-20       Impact factor: 7.396

3.  A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Authors:  V N Kristensen; T I Andersen; A Lindblom; B Erikstein; P Magnus; A L Børresen-Dale
Journal:  Pharmacogenetics       Date:  1998-02

4.  Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

Authors:  Alison M Dunning; Mitch Dowsett; Catherine S Healey; Louise Tee; Robert N Luben; Elizabeth Folkerd; Karen L Novik; Livia Kelemen; Saeko Ogata; Paul D P Pharoah; Douglas F Easton; N E Day; Bruce A J Ponder
Journal:  J Natl Cancer Inst       Date:  2004-06-16       Impact factor: 13.506

Review 5.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

6.  A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.

Authors:  Kathryn E Talbott; Marilie D Gammon; Muhammad G Kibriya; Yu Chen; Susan L Teitelbaum; Chang-Min Long; Irina Gurvich; Regina M Santella; Habibul Ahsan
Journal:  Breast Cancer Res Treat       Date:  2007-11-02       Impact factor: 4.872

7.  Association between gynecomastia and aromatase (CYP19) polymorphisms.

Authors:  Izabella Czajka-Oraniec; Wojciech Zgliczynski; Alina Kurylowicz; Michal Mikula; Jerzy Ostrowski
Journal:  Eur J Endocrinol       Date:  2008-05       Impact factor: 6.664

8.  Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis.

Authors:  Sung Eun Hur; Sara Lee; Ji Young Lee; Hye-Sung Moon; Hyung Lae Kim; Hye Won Chung
Journal:  J Hum Genet       Date:  2007-08-09       Impact factor: 3.172

9.  Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men.

Authors:  Anna L Eriksson; Mattias Lorentzon; Liesbeth Vandenput; Fernand Labrie; Marie Lindersson; Ann-Christine Syvänen; Eric S Orwoll; Steven R Cummings; Joseph M Zmuda; Osten Ljunggren; Magnus K Karlsson; Dan Mellström; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

10.  Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.

Authors:  Kazuhiro Suzuki; Haruki Nakazato; Hiroshi Matsui; Hidekazu Koike; Hironobu Okugi; Nobuaki Ohtake; Tomoyuki Takei; Seiji Nakata; Masaru Hasumi; Hidetoshi Yamanaka
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

View more
  11 in total

Review 1.  Obesity: modern man's fertility nemesis.

Authors:  Stephanie Cabler; Ashok Agarwal; Margot Flint; Stefan S du Plessis
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 2.  [Gender Obesity Report--Influence of obesity on Reproduction and Pregnancy].

Authors:  Jürgen Harreiter; Alexandra Kautzky-Willer
Journal:  Wien Med Wochenschr       Date:  2015-12-09

Review 3.  Hormone-Based Treatments in Subfertile Males.

Authors:  Darshan P Patel; Jason C Chandrapal; James M Hotaling
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 4.  Estrogens and Body Weight Regulation in Men.

Authors:  Katya B Rubinow
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 5.  Updates on the relation of weight excess and reproductive function in men: sleep apnea as a new area of interest.

Authors:  Ahmad O Hammoud; Douglas T Carrell; Mark Gibson; C Matthew Peterson; A Wayne Meikle
Journal:  Asian J Androl       Date:  2011-12-05       Impact factor: 3.285

Review 6.  Clinical management of infertile men with nonobstructive azoospermia.

Authors:  Sandro C Esteves
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

7.  Diet-induced obesity impairs spermatogenesis: a potential role for autophagy.

Authors:  Yang Mu; Wen-Jie Yan; Tai-Lang Yin; Yan Zhang; Jie Li; Jing Yang
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

8.  Irisin alleviates obesity-related spermatogenesis dysfunction via the regulation of the AMPKα signalling pathway.

Authors:  Yang Mu; Huang-Guan Dai; Ling-Bo Luo; Jing Yang
Journal:  Reprod Biol Endocrinol       Date:  2021-09-08       Impact factor: 5.211

Review 9.  Inositols: From Established Knowledge to Novel Approaches.

Authors:  Simona Dinicola; Vittorio Unfer; Fabio Facchinetti; Christophe O Soulage; Nicholas D Greene; Mariano Bizzarri; Antonio Simone Laganà; Shiao-Yng Chan; Arturo Bevilacqua; Lali Pkhaladze; Salvatore Benvenga; Annarita Stringaro; Daniele Barbaro; Marialuisa Appetecchia; Cesare Aragona; Maria Salomè Bezerra Espinola; Tonino Cantelmi; Pietro Cavalli; Tony T Chiu; Andrew J Copp; Rosario D'Anna; Didier Dewailly; Cherubino Di Lorenzo; Evanthia Diamanti-Kandarakis; Imelda Hernández Marín; Moshe Hod; Zdravko Kamenov; Eleni Kandaraki; Giovanni Monastra; Mario Montanino Oliva; John E Nestler; Maurizio Nordio; Ali C Ozay; Olga Papalou; Giuseppina Porcaro; Nikos Prapas; Scott Roseff; Monica Vazquez-Levin; Ivana Vucenik; Artur Wdowiak
Journal:  Int J Mol Sci       Date:  2021-09-30       Impact factor: 5.923

Review 10.  Testosterone-induced effects on lipids and inflammation.

Authors:  Stella Vodo; Nicoletta Bechi; Anna Petroni; Carolina Muscoli; Anna Maria Aloisi
Journal:  Mediators Inflamm       Date:  2013-03-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.